Precision BioSciences
DTIL
79 hedge funds and large institutions have $88.3M invested in Precision BioSciences in 2026 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 11 closing their positions.
112% more capital inflows, than outflows
Capital inflows: $17.6M | Capital outflows: $8.33M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
92% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 13
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
13% more funds holding
Funds holding: 70 → 79 (+9)
4.31% more ownership
Funds ownership: 61.12% → 65.43% (+4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Affinity Asset Advisors
New York
|
+$2.76M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.59M |
| 3 |
Octagon Capital Advisors
New York
|
+$1.47M |
| 4 |
Driehaus Capital Management
Chicago,
Illinois
|
+$958K |
| 5 |
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$826K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.04M |
| 2 |
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.64M |
| 3 |
Empery Asset Management
New York
|
-$1.04M |
| 4 |
Renaissance Technologies
New York
|
-$477K |
| 5 |
6CM
683 Capital Management
New York
|
-$404K |
DTIL Hedge Fund Activity: Q1 2026 in Review
79 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2026, worth a combined $88.3M — up 40% from $62.9M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new DTIL positions and 11 closed out — a net gain of 10 holders — while 25 added to existing stakes and 13 trimmed.
The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $2.76M. The largest seller was Alyeska Investment Group, cutting an estimated $3.04M.
- 79 institutional investors held Precision BioSciences (DTIL) as of Q1 2026, up from 70 in Q4 2025.
- Funds reported $88.3M of Precision BioSciences stock for Q1 2026, up 40% quarter-over-quarter.
- 21 funds opened new Precision BioSciences positions in Q1 2026 and 11 closed out, a net change of +10 holders.
- The largest Precision BioSciences buyer in Q1 2026 was Affinity Asset Advisors, an estimated $2.76M added.
- The largest Precision BioSciences seller in Q1 2026 was Alyeska Investment Group, an estimated $3.04M sold.
Based on aggregated 13F filings for Q1 2026.